Association of serum metabolites and breast cancer risk: A population‐based case–control study in black urban South African women
International Journal of Cancer · 15.10.2025 · 157 (8) · 1543-1556
DOI: 10.1002/ijc.35503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 17.06.2025. Verfasst von Yahya Mahamat-Saleh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: World Health Organization, NCI NIH HHS, World Cancer Research Fund International.
Abstract (Originalsprache)
The incidence of breast cancer has been steadily increasing in South Africa over the past decades, but this rise can only be partially attributed to changes in known modifiable risk factors. Metabolomics may help to elucidate novel biological pathways and identify potential biomarkers associated with cancer. We investigated the association between serum metabolites and breast cancer risk in black women from Soweto, South Africa. An untargeted ultra‐high‐performance LC–MS method was used to measure molecular features in serum samples from a total of 396 breast cancer cases and 396 population‐based controls matched on age and demographic settings, enrolled in the South African Breast Cancer study. A total of 5820 features were detected from metabolomics analyses and 1732 were retained for statistical analysis after data pre‐processing and imputation. Multivariable conditional logistic regression was used to estimate odds ratios (ORs) and false discovery rate‐adjusted (FDR) confidence interval (CI) for the association of metabolite features and breast cancer risk. Overall, 12 molecular features were significantly associated with odds of breast cancer (FDR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
- Centre of Excellence for Nutrition, North-West University, Potchefstroom, South Africa.
- Non-Communicable Diseases Research Division, Wits Health Consortium (PTY) Ltd., Johannesburg, South Africa.
- Department of Paediatrics, Faculty of Health Sciences, MRC Developmental Pathways to Health Research Unit, University of Witwatersrand, Johannesburg, South Africa.
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
ORCID-Profile: Yahya Mahamat-Saleh, Pekka Keski-Rahkonen, Sabina Rinaldi
Förderung
- World Health Organization
- NCI NIH HHS
- World Cancer Research Fund International
Zitieren
APA
Mahamat-Saleh, Y., Merdas, M., Viallon, V., Robinot, N., Biessy, C., Jacobs, I., Taljaard-Krugell, C., Zandberg, L., Joffe, M., Gunter, M. J., Keski-Rahkonen, P., Dossus, L., & Rinaldi, S. (2025). Association of serum metabolites and breast cancer risk: A population‐based case–control study in black urban South African women. International Journal of Cancer, 157(8), 1543-1556. https://doi.org/10.1002/ijc.35503
Vancouver
Mahamat-Saleh Y, Merdas M, Viallon V, Robinot N, Biessy C, Jacobs I, et al. Association of serum metabolites and breast cancer risk: A population‐based case–control study in black urban South African women. International Journal of Cancer. 2025;157(8):1543-1556. doi:10.1002/ijc.35503
BibTeX
@article{MahamatSaleh2025,
author = {Mahamat-Saleh, Yahya and Merdas, Mira and Viallon, Vivian and Robinot, Nivonirina and Biessy, Carine and Jacobs, Inarie and Taljaard-Krugell, Christine and Zandberg, Lizelle and Joffe, Maureen and Gunter, Marc J and Keski-Rahkonen, Pekka and Dossus, Laure and Rinaldi, Sabina},
title = {Association of serum metabolites and breast cancer risk: A population‐based case–control study in black urban South African women},
journal = {International Journal of Cancer},
year = {2025},
volume = {157},
number = {8},
pages = {1543--1556},
doi = {10.1002/ijc.35503}
}
EUVIMED